Company presentation at Mello 2026
IXICO plc announced that its CEO will present at the Mello2026 investor event on June 3rd, 2026, to discuss recent positive financial results from May 19th, 2026, the company's growth trajectory, and future strategy. The presentation will highlight IXICO's role as a leader in neuroscience imaging and biomarker analytics, utilizing its AI-driven platform to advance drug and diagnostics development for neurological disorders.
Select text to share a quote on X · sign in to keep highlights & notes in your IXI notes
22 May 2026, IXICO plc (AIM: IXI) - London, UK. IXICO, a global leader in neuroscience imaging and biomarker analytics, using its AI-driven platform to help advance drug and diagnostics development in neurological disorders, is pleased to announce that the Company will be presenting at the Mello2026 investor event at 13:55 (BST) on Wednesday 3rd June 2026, to be held at The Clayton Hotel & Conference Centre, Chiswick High Road, London, W4 5RY.
Bram Goorden, CEO of IXICO will present on the recent positive financial results announced on 19 May 2026, current growth trajectory and future strategy of the Company.
For further information and tickets (use code SHM2026 for 25% off ticket price) for the Mello2026 conference, please visit the event website at www.melloevents.com/mello2026
Cleaned text: letterheads, contacts and legal notices removed. View the original announcement ↗ · Company filings. Not investment advice.